Sitagliptin ameliorates the progression of atherosclerosis via down regulation of the inflammatory and oxidative pathways
Back ground: Atherosclerosis is the major cause of death. The most common risk factors are hyperlipidemia, diabetes, and other factors like chronic infection and inflammation. Objective: This study was undertaken to assess the effect of sitagliptin on atherosclerosis via interfering with inflammator...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2013-09-01
|
| Series: | SAGE Open Medicine |
| Online Access: | https://doi.org/10.1177/2050312113499912 |